Schedule a demo or speak with one of our experts today
IQVIA Analytics Link Ecosystem establishes deep connections across our key data assets.
IQVIA MIDAS® has long been considered the industry benchmark for global market measurement, integrating the breadth and depth of IQVIA's unparalleled data assets with advanced analytics and deep domain expertise across 95 countries.
Just launched, MIDAS Patient adds patient insights across 600 diseases at scale to evolve with industry transformation towards multi-indication drugs and ensuring patient-centricity at the forefront. Life sciences organizations can now easily make disease comparisons supported by patient metrics across the MIDAS universe.
Hyper-segment your market and competitive landscape by 600+ diseases and 35 tumors with MIDAS Disease.
MIDAS Disease sources optimal syndicated disease segmentation inputs from across IQVIA and seamlessly integrates them with harmonized sales data to provide drug-by-disease insights and total disease market sizing for the entire MIDAS universe.
Quantify estimated drug-treated patients and associated measures by drugs and diseases at-scale with MIDAS Patient.
MIDAS Patient revolutionizes market measurement by delivering comprehensive patient insights across all MIDAS-covered markets and products, fully harmonized for cross-country comparison. It integrates patient dynamics with disease metrics, allowing you to unravel complex patient landscapes.
Join this webinar to review key pharma metrics for 2024, understand driving forces behind current healthcare market challenges and discover strategies to overcome them.
IQVIA Analytics Link Ecosystem establishes deep connections across our key data assets.
Strengthen your portfolio by making more informed decisions and prepare for the impact of new research discoveries.
Measure the performance of your sales force and marketing channels, adapt your commercial strategy and gain real world competitive insights.
Access 470,000 products and nearly 40,000 drug profiles to analyze successful launch strategies and be ready for what’s next.
Track more than 60,000 pharmaceutical patent families across 130 countries to find opportunities and ensure timely business decisions.
Accelerate strategic decision making with a clear view on future market dynamics, now powered by AI